174 related articles for article (PubMed ID: 25177587)
1. HIV Associated Sensory Neuropathy.
G A; S PK; B N; Bs N
J Clin Diagn Res; 2014 Jul; 8(7):MC04-7. PubMed ID: 25177587
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
Morgello S; Estanislao L; Simpson D; Geraci A; DiRocco A; Gerits P; Ryan E; Yakoushina T; Khan S; Mahboob R; Naseer M; Dorfman D; Sharp V;
Arch Neurol; 2004 Apr; 61(4):546-51. PubMed ID: 15096404
[TBL] [Abstract][Full Text] [Related]
3. HIV peripheral neuropathy.
Gabbai AA; Castelo A; Oliveira AS
Handb Clin Neurol; 2013; 115():515-29. PubMed ID: 23931799
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
Spruance SL; Pavia AT; Mellors JW; Murphy R; Gathe J; Stool E; Jemsek JG; Dellamonica P; Cross A; Dunkle L
Ann Intern Med; 1997 Mar; 126(5):355-63. PubMed ID: 9054279
[TBL] [Abstract][Full Text] [Related]
5. Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy.
Oshinaike O; Akinbami A; Ojo O; Ogbera A; Okubadejo N; Ojini F; Danesi M
AIDS Res Treat; 2012; 2012():961510. PubMed ID: 22570772
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
[TBL] [Abstract][Full Text] [Related]
7. Effect of stavudine-based antiretroviral therapy on the severity of polyneuropathy in HIV/AIDS patients: a preliminary report from Zaria, Northern Nigeria.
Obiako OR; Abdu-Aguye I; Ogunniyi A
West Afr J Med; 2011; 30(5):354-8. PubMed ID: 22752824
[TBL] [Abstract][Full Text] [Related]
8. Clinical diagnosis of sensory neuropathy in HIV patients treated with tenofovir: A 6-month follow-up study.
Pillay P; Wadley AL; Cherry CL; Karstaedt AS; Kamerman PR
J Peripher Nerv Syst; 2019 Dec; 24(4):304-313. PubMed ID: 31587421
[TBL] [Abstract][Full Text] [Related]
9. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.
Ellis RJ; Rosario D; Clifford DB; McArthur JC; Simpson D; Alexander T; Gelman BB; Vaida F; Collier A; Marra CM; Ances B; Atkinson JH; Dworkin RH; Morgello S; Grant I;
Arch Neurol; 2010 May; 67(5):552-8. PubMed ID: 20457954
[TBL] [Abstract][Full Text] [Related]
10. The role of CAMKK2 polymorphisms in HIV-associated sensory neuropathy in South Africans.
Gaff J; Pillay P; Cherry C; Laws SM; Price P; Kamerman P
J Neurol Sci; 2020 Sep; 416():116987. PubMed ID: 32585444
[TBL] [Abstract][Full Text] [Related]
11. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.
Shurie JS; Deribew A
Ethiop Med J; 2010 Apr; 48(2):85-93. PubMed ID: 20608012
[TBL] [Abstract][Full Text] [Related]
13. Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.
Shikuma CM; Bennett K; Ananworanich J; Gerschenson M; Teeratakulpisarn N; Jadwattanakul T; DeGruttola V; McArthur JC; Ebenezer G; Chomchey N; Praihirunkit P; Hongchookiat P; Mathajittiphun P; Nakamoto B; Hauer P; Phanuphak P; Phanuphak N;
J Neurovirol; 2015 Oct; 21(5):525-34. PubMed ID: 26002840
[TBL] [Abstract][Full Text] [Related]
14. [Polyneuropathies in patients treated with HAART in Bobo-Dioulasso hospital, Burkina Faso].
Millogo A; Lankoandé D; Yaméogo I; Yaméogo AA; Sawadogo AB
Bull Soc Pathol Exot; 2008 Feb; 101(1):11-3. PubMed ID: 18431998
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort.
Cherry CL; Skolasky RL; Lal L; Creighton J; Hauer P; Raman SP; Moore R; Carter K; Thomas D; Ebenezer GJ; Wesselingh SL; McArthur JC
Neurology; 2006 Mar; 66(6):867-73. PubMed ID: 16567704
[TBL] [Abstract][Full Text] [Related]
16. Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda.
Sacktor N; Nakasujja N; Skolasky RL; Robertson K; Musisi S; Ronald A; Katabira E; Clifford DB
Neurology; 2009 Jan; 72(2):165-70. PubMed ID: 19139369
[TBL] [Abstract][Full Text] [Related]
17. HIV neuropathy.
Kaku M; Simpson DM
Curr Opin HIV AIDS; 2014 Nov; 9(6):521-6. PubMed ID: 25275705
[TBL] [Abstract][Full Text] [Related]
18. Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study.
Palacios R; Santos J; Camino X; Arazo P; Torres Perea R; Echevarrfa S; Ribera E; Sánchez de la Rosa R; Moreno Guillen S;
Curr Ther Res Clin Exp; 2005 Mar; 66(2):117-29. PubMed ID: 24672118
[TBL] [Abstract][Full Text] [Related]
19. Clinical and electrophysiologic evaluation of peripheral neuropathy in a group of HIV-infected patients in Thailand.
Konchalard K; Wangphonpattanasiri K
J Med Assoc Thai; 2007 Apr; 90(4):774-81. PubMed ID: 17487134
[TBL] [Abstract][Full Text] [Related]
20. Peripheral neuropathy in children on stauvudine therapy.
Sankhyan N; Lodha R; Sharma S; Menon PR; Choudhary A; Kabra SK; Gulati S
Indian J Pediatr; 2015 Feb; 82(2):136-9. PubMed ID: 24874810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
